Biothreat Detection Systems Market Report 2026

The biothreat detection systems market size has grown strongly in recent years. It will grow from $2.18 billion in 2025 to $2.39 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing public health surveillance initiatives, rising investment in biodefense programs, expansion of laboratory diagnostic capabilities, growing awareness of pandemic preparedness, adoption of molecular detection platforms.

The biothreat detection systems market size is expected to see strong growth in the next few years. It will grow to $3.49 billion in 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing demand for early-warning biothreat systems, rising integration of AI-driven analytics, expansion of environmental monitoring networks, growing focus on national biosecurity strategies, increasing adoption of portable field-deployable systems. Major trends in the forecast period include increasing deployment of automated bioaerosol monitoring systems, rising adoption of rapid molecular detection technologies, expansion of integrated surveillance networks, growing use of portable detection kits, enhanced focus on real-time threat analytics.

The growth of defense and homeland security budgets is projected to drive the expansion of the biothreat detection systems market in the future. Defense and homeland security budgets refer to government-assigned financial resources allocated for national defense, military operations, intelligence, border protection, counterterrorism, emergency preparedness, and safeguarding critical infrastructure and public safety. These budgets are increasing due to escalating geopolitical tensions that necessitate enhanced investment in national security and threat preparedness. Biothreat detection systems support defense and homeland security efforts by facilitating early detection and rapid response to biological threats, reducing the cost and consequences of large-scale outbreaks, emergency interventions, and national security events. For example, in April 2025, according to the Stockholm International Peace Research Institute (SIPRI), an independent international institute based in Sweden, the United Kingdom increased its military spending in 2024 by 2.8% to $81.8 billion, making it the world’s sixth-largest defense spender. Therefore, the expansion of defense and homeland security budgets is driving the growth of the biothreat detection systems market.

Key companies operating in the biothreat detection systems market are focusing on advancing continuous biological surveillance technologies, such as real-time aerosol-based pathogen monitoring systems, to enable early detection of airborne biological threats in public and critical infrastructure settings. Real-time aerosol-based pathogen monitoring systems continuously collect and analyze air samples to identify biological agents, which allows authorities to detect emerging health threats or deliberate releases before widespread exposure occurs. For example, in August 2023, BioFlyte Inc., a US-based biodefense technology company, launched a first-of-its-kind biothreat surveillance pilot program at Pittsburgh International Airport. The pilot deploys autonomous air-sampling and pathogen detection units throughout airport facilities, enables near real-time identification of airborne biological threats, and integrates alerting capabilities to support rapid response by public health and security teams, strengthening early-warning preparedness for high-traffic transportation hubs.

In July 2025, XBridge LLC, a US-based healthcare company, partnered with BioFlyte to deploy cutting-edge aerosol-based biothreat detection technology for continuous biological monitoring in high-risk public settings. This collaboration enables XBridge to strengthen early-warning capabilities for airborne biological hazards by implementing continuous aerosol detection and real-time pathogen monitoring systems at Pittsburgh International Airport. BioFlyte Inc. is a US-based company that offers an innovative type of field-deployable biological threat collection technology.

Major companies operating in the biothreat detection systems market are Roche Diagnostics AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Eurofins Scientific SE, Agilent Technologies Inc., Battelle Memorial Institute, Illumina Inc., Smiths Group, Shimadzu Corporation, Bruker Corporation, Bio Rad Laboratories Inc., QIAGEN NV, Tecan Group Ltd., DiaSorin S.p.A., Emergent BioSolutions Inc., Physical Sciences Inc, DetectaChem Inc., PositiveID Corporation, AdVnt Biotechnologies, Alexeter Technologies LLC.

Tariffs are impacting the biothreat detection systems market by increasing costs of imported biosensors, PCR instruments, analytical detectors, electronic components, and precision sampling devices. Government agencies and healthcare institutions in North America and Europe are most affected due to reliance on advanced imported detection technologies, while Asia-Pacific faces higher costs for manufacturing and exporting detection systems. These tariffs are increasing procurement budgets and delaying system upgrades. However, they are also driving domestic production, regional supplier development, and innovation in cost-effective and locally manufactured biothreat detection solutions.

The biothreat detection systems market research report is one of a series of new reports that provides biothreat detection systems market statistics, including biothreat detection systems industry global market size, regional shares, competitors with a biothreat detection systems market share, detailed biothreat detection systems market segments, market trends and opportunities, and any further data you may need to thrive in the biothreat detection systems industry. This biothreat detection systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biothreat detection systems are integrated solutions designed to identify, detect, and monitor harmful biological agents such as viruses, bacteria, and toxins that pose risks to public health or national security. These systems provide early warning and rapid response capabilities by integrating sensors, laboratory diagnostics, and data analytics to recognize naturally occurring outbreaks or intentional biological threats.

The primary types of biothreat detection systems include polymerase chain reaction-based detection, immunological detection, biosensors, microarrays, and other technologies. Polymerase chain reaction-based detection refers to systems that identify and quantify pathogens or hazardous biological agents by amplifying specific segments of their genetic material. These systems detect biological agents, chemical agents, and radiological agents. They are applied across areas including military and defense, public health, environmental monitoring, agriculture, and other applications, and are used by end users including government agencies, hospitals and healthcare facilities, research laboratories, commercial and industrial organizations, and other end users.

The biothreat detection systems market consists of sales of biosensors, polymerase chain reaction instruments, immunoassay analyzers, air sampling devices, bioaerosol collectors, portable detection kits, microbial detection reagents, automated sample preparation systems, and environmental monitoring detectors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.